Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome

Opsoclonus-myoclonus-ataxia syndrome (OMAS) in children is most often of paraneoplastic origin, but it can also result from infectious processes, toxic and metabolic disorders, and organic events that cause damage to the brainstem or cerebellum. Post-vaccination OMAS has also been reported. We repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Deniz, Adnan, Alikılıç, Defne, Öztürk, Merve, Karaca, Ömer, Güngör, Mesut, Kara, Bülent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886563/
https://www.ncbi.nlm.nih.gov/pubmed/36736453
http://dx.doi.org/10.1016/j.jaapos.2022.12.001
_version_ 1784880157117382656
author Deniz, Adnan
Alikılıç, Defne
Öztürk, Merve
Karaca, Ömer
Güngör, Mesut
Kara, Bülent
author_facet Deniz, Adnan
Alikılıç, Defne
Öztürk, Merve
Karaca, Ömer
Güngör, Mesut
Kara, Bülent
author_sort Deniz, Adnan
collection PubMed
description Opsoclonus-myoclonus-ataxia syndrome (OMAS) in children is most often of paraneoplastic origin, but it can also result from infectious processes, toxic and metabolic disorders, and organic events that cause damage to the brainstem or cerebellum. Post-vaccination OMAS has also been reported. We report the case of a 15-year-old girl who developed OMAS 24 hours after her first dose of mRNA COVID-19 (BioNTech) vaccine.
format Online
Article
Text
id pubmed-9886563
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-98865632023-01-31 Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome Deniz, Adnan Alikılıç, Defne Öztürk, Merve Karaca, Ömer Güngör, Mesut Kara, Bülent J AAPOS Short Report Opsoclonus-myoclonus-ataxia syndrome (OMAS) in children is most often of paraneoplastic origin, but it can also result from infectious processes, toxic and metabolic disorders, and organic events that cause damage to the brainstem or cerebellum. Post-vaccination OMAS has also been reported. We report the case of a 15-year-old girl who developed OMAS 24 hours after her first dose of mRNA COVID-19 (BioNTech) vaccine. American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. 2023-04 2023-01-31 /pmc/articles/PMC9886563/ /pubmed/36736453 http://dx.doi.org/10.1016/j.jaapos.2022.12.001 Text en © 2023 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Report
Deniz, Adnan
Alikılıç, Defne
Öztürk, Merve
Karaca, Ömer
Güngör, Mesut
Kara, Bülent
Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome
title Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome
title_full Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome
title_fullStr Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome
title_full_unstemmed Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome
title_short Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome
title_sort probable association between mrna covid-19 vaccine and opsoclonus-myoclonus-ataxia syndrome
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886563/
https://www.ncbi.nlm.nih.gov/pubmed/36736453
http://dx.doi.org/10.1016/j.jaapos.2022.12.001
work_keys_str_mv AT denizadnan probableassociationbetweenmrnacovid19vaccineandopsoclonusmyoclonusataxiasyndrome
AT alikılıcdefne probableassociationbetweenmrnacovid19vaccineandopsoclonusmyoclonusataxiasyndrome
AT ozturkmerve probableassociationbetweenmrnacovid19vaccineandopsoclonusmyoclonusataxiasyndrome
AT karacaomer probableassociationbetweenmrnacovid19vaccineandopsoclonusmyoclonusataxiasyndrome
AT gungormesut probableassociationbetweenmrnacovid19vaccineandopsoclonusmyoclonusataxiasyndrome
AT karabulent probableassociationbetweenmrnacovid19vaccineandopsoclonusmyoclonusataxiasyndrome

Ejemplares similares